Ablynx NV logo

ABLX - Ablynx NV Share Price

$52.87 0.1  0.2%

Last Trade - 12/06/18

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £47.3m
Position in Universe th / 6415
Bullish
Bearish
Unlock ABLX Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ABLX Revenue Unlock ABLX Revenue

Net Income

ABLX Net Income Unlock ABLX Revenue

Normalised EPS

ABLX Normalised EPS Unlock ABLX Revenue

PE Ratio Range

ABLX PE Ratio Range Unlock ABLX Revenue

Dividend Yield Range

ABLX Dividend Yield Range Unlock ABLX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ABLX EPS Forecasts Unlock ABLX Revenue
Profile Summary

Ablynx NV is a Belgium-based biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments, which combine the advantages of conventional antibody drugs with some of the features of small-molecule drugs. Ablynx NV has more than 30 proprietary and partnered programmes in development in various therapeutic areas including inflammation, haematology, immuno-oncology, oncology and respiratory disease. The Company has collaborations with multiple pharmaceutical companies including AbbVie, Boehringer Ingelheim, Eddingpharm, Genzyme, Merck & Co, Inc., Merck Serono and Novartis.

Directors
Last Annual December 31st, 2017
Last Interim December 31st, 2017
Incorporated July 13, 2001
Public Since March 9, 2010
No. of Shareholders: n/a
No. of Employees: 438
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange NASDAQ Global Select Market (Dual Listing)
Shares in Issue 78,001,392
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ABLX Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Similar to ABLX
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.